These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7249489)

  • 1. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
    Bodemar G; Norlander B; Walan A
    Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of cimetidine.
    Somogyi A; Gugler R
    Clin Pharmacokinet; 1983; 8(6):463-95. PubMed ID: 6418428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.
    Bodemar G; Norlander B; Fransson L; Walan A
    Br J Clin Pharmacol; 1979 Jan; 7(1):23-31. PubMed ID: 760739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of oral and intravenous cimetidine in seriously ill patients.
    Sandborn WJ; Forland SC; Cutler RE; Strong RM
    J Clin Pharmacol; 1990 Jun; 30(6):568-71. PubMed ID: 2355107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cimetidine pharmacokinetics].
    Katrukha SP; Karpenko EV; Davydov SM; Blinkov IL; Kukes VG
    Farmakol Toksikol; 1986; 49(5):36-40. PubMed ID: 3770173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
    Bjaeldager PA; Jensen JB; Larsen NE; Hvidberg EF
    Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine pharmacokinetics and dosage requirements in children.
    Somogyi A; Becker M; Gugler R
    Eur J Pediatr; 1985 May; 144(1):72-6. PubMed ID: 4018106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of cimetidine in man.
    Walkenstein SS; Dubb JW; Randolph WC; Westlake WJ; Stote RM; Intoccia AP
    Gastroenterology; 1978 Feb; 74(2 Pt 2):360-5. PubMed ID: 620910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of phenobarbital treatment on cimetidine kinetics.
    Somogyi A; Thielscher S; Gugler R
    Eur J Clin Pharmacol; 1981; 19(5):343-7. PubMed ID: 7238562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
    Bjaeldager PA; Jensen JB; Nielsen LP; Larsen NE; Hvidberg EF
    Nephron; 1983; 34(3):159-63. PubMed ID: 6877447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine kinetics and dynamics in patients with severe liver disease.
    Villeneuve JP; Fortunet-Fouin H; Arsène D
    Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.
    Larsson R; Erlanson P; Bodemar G; Norlander B; Fransson L; Strouth L
    Eur J Clin Pharmacol; 1982; 21(4):325-30. PubMed ID: 7056278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.